August 26, 2016 7:58 AM ET


Company Overview of ProtAffin Biotechnologie AG

Company Overview

ProtAffin Biotechnologie AG, a pre-clinical stage biotechnology company, develops protein-based biopharmaceutical products for chronic inflammatory diseases and oncology. It develops products based on CellJammer, a discovery technology for targeting protein-glycan interactions using modified human proteins. The company’s products include PA401, which is a modified form of the human chemokine IL-8 and acts as an anti-inflammatory protein preventing the infiltration of neutrophils in chronic respiratory diseases and acute inflammatory diseases. ProtAffin Biotechnologie AG was founded in 2005 and is based in Graz, Austria with an additional office in Vienna, Austria.

Impulszentrum Graz-West

Reininghausstrasse 13a

Graz,  8020


Founded in 2005


43 316 382 541


43 316 382 541 4

Key Executives for ProtAffin Biotechnologie AG

Co-Founder and Chief Scientific Officer
Chief Development officer
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
Activartis Biotech GmbH Europe
APEIRON Biologics AG Europe
Apeptico Forschung und Entwicklung GmbH Europe
Aposcience AG Europe
ARTMA Medical Technologies AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ProtAffin Biotechnologie AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at